Free tool
FAERS Monitor: Sensipar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021688 or its brand name (Sensipar, Cinacalcet Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
46,374
Serious
16,981
37% of reports
Hospitalization
11,095
Death reported
2,520
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dose omission8,738
- hospitalisation6,929
- laboratory test abnormal4,222
- off label use2,501
- nausea2,285
- intentional product misuse2,084
- death1,834
- malaise1,563
- vomiting1,546
- adverse drug reaction1,461
- diarrhoea1,137
- decreased appetite828
- abdominal discomfort775
- muscle spasms600
- hypotension578
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 104 |
| 2005 | 127 |
| 2006 | 221 |
| 2007 | 121 |
| 2008 | 269 |
| 2009 | 317 |
| 2010 | 399 |
| 2011 | 509 |
| 2012 | 531 |
| 2013 | 789 |
| 2014 | 1,009 |
| 2015 | 7,880 |
| 2016 | 7,587 |
| 2017 | 10,651 |
| 2018 | 12,675 |
| 2019 | 773 |
| 2020 | 388 |
| 2021 | 329 |
| 2022 | 446 |
| 2023 | 413 |
| 2024 | 422 |
| 2025 | 287 |
| 2026 | 127 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,007,785 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| laboratory test abnormalSignal | 4,222 | 75.5 | 73.2 | 266,469 |
| drug dose omissionSignal | 8,738 | 25.3 | 24.8 | 194,303 |
| hospitalisationSignal | 6,929 | 21.4 | 20.9 | 129,410 |
| intentional product misuseSignal | 2,084 | 11.0 | 10.6 | 18,633 |
| adverse drug reactionSignal | 1,461 | 7.5 | 7.1 | 8,100 |
| abdominal discomfortSignal | 775 | 2.1 | 2.0 | 447 |
| decreased appetite | 828 | 1.6 | 1.5 | 197 |
| malaise | 1,563 | 1.6 | 1.5 | 375 |
| vomiting | 1,546 | 1.5 | 1.4 | 256 |
| muscle spasms | 600 | 1.5 | 1.4 | 95 |
| nausea | 2,285 | 1.3 | 1.3 | 174 |
| hypotension | 578 | 1.3 | 1.2 | 42 |
| off label use | 2,501 | 1.3 | 1.2 | 176 |
| death | 1,834 | 1.0 | 0.9 | 2 |
| diarrhoea | 1,137 | 0.8 | 0.8 | 59 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.